Alberto Cascon obtained his BSc (1993) and PhD in Biology (2000) from the University of León (Spain). In 2001 he was awarded a Postdoctoral Fellowship by the Madrid City Council and took up position with the Hereditary Endocrine Cancer Group at the Spanish National Cancer Research Centre (CNIO) in Madrid. In 2004, he was awarded a Fellowship by the Spanish Department of Health, and became a Staff Scientist in the same group at the CNIO, led by Dra. Mercedes Robledo. Since 2001 he has been investigating the genetics of pheochromoctymas and paragangliomas, a subject on which he has focused 40 of his more than 70 published manuscripts. During the last years, he has conducted various exome sequencing projects which have led to the discovery of two new pheochromocytoma/paraganglioma susceptibility genes: MAX and MDH2. In 2012, his paper reporting the discovery of MAX was awarded publication of the year by the Fundación Mutua Madrileña.